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ABSTRACT
A gene encoding a putative DNA helicase from
Staphylococcus aureus USA300 was cloned and ex-
pressed in Escherichia coli. The protein was purified
to over 90% purity by chromatography. The purified
enzyme, SauUSI, predominantly cleaves modified
DNA containing 5mC and 5-hydroxymethylcytosine.
Cleavage of 5mC-modified plasmids indicated that
the sites S5mCNGS (S=C or G) are preferentially
digested. The endonuclease activity requires the
presence of adenosine triphosphate (ATP) or dATP
whereas the non-hydrolyzable c-S-ATP does not
support activity. SauUSI activity was inhibited by
ethylenediaminetetraacetic acid. It is most active
in Mg
+ + buffers. No companion methylase gene
was found near the SauUSI restriction gene. The
absence of a cognate methylase and cleavage of
modified DNA indicate that SauUSI belongs to type
IV restriction endonucleases, a group that includes
EcoK McrBC and Mrr. SauUSI belongs to a family
of highly similar homologs found in other sequenced
S. aureus, S. epidermidis and S. carnosus genomes.
More distant SauUSI orthologs can be found in
over 150 sequenced bacterial/archaea genomes.
Finally, we demonstrated the biological function
of the type IV REase in restricting 5mC-modified
plasmid DNA by transformation into clinical
S. aureus strain SA564, and in restricting phage j
infection when the endonuclease is expressed in
E. coli.
INTRODUCTION
Restriction enzymes (REases) are grouped into four major
types based on subunit architecture, adenosine triphos-
phate/guanosine triphosphate (ATP/GTP) requirement,
sequence speciﬁcity and DNA cleavage mechanism (1).
Type I restriction–modiﬁcation (R–M) systems were ori-
ginally discovered by studying phage plating efﬁciency
among different Escherichia coli hosts (2). Type I restric-
tion enzymes are multi-subunit complexes consisting of
M2R2S subunits, and their activity requires ATP hydroly-
sis (3). Type II REases with 4–8-bp recognition sequences
and over 300 unique speciﬁcities are widely used in
creating recombinant DNA molecules (4). Type III R–M
systems are also multi-subunit complexes with R2M2 con-
ﬁguration and require ATP hydrolysis for endonuclease
activity (5–7). Two recognition sites in head-to-head or
tail-to-tail orientations are essential for type I and type
III enzymes to cleave. Modiﬁcation-dependent REases
are presently grouped into type IIM if the target
sequence recognition and cleavage are very speciﬁc and
precise, for example, DpnI, GN6mATC (8) and GlaI,
G5mCG5mC (9), MspJI, 5mCNNR (10); or type IV if
cleavage is non-speciﬁc and variable. Examples of type
IV are McrBC, which cleaves 5mC-modiﬁed DNA, and
GmrSD that attacks glucosylated-hmC (glc-5hmC) T4
DNA (11–15).
Methicillin-resistant Staphylococcus aureus (MRSA)
presents a great health threat by hospital-acquired infec-
tions (HaMRSA) and more recently by community
acquired (CaMRSA) infections characterized by the
spread of highly invasive and persistent infections
(16,17). Recently, the ability of MRSA strains to acquire
vancomycin-resistance genes from Enterococcus species
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studies have been carried out to elucidate the mechanism
of antibiotic resistance. The general conclusion is that
drug resistance genes can be chromosomally encoded or
derived from extra chromosomal elements, and acquired
by horizontal gene transfer of mobile genetic elements
such as conjugative plasmids, transposable elements,
integrons or by phage infection and integration (22). The
presence of type I, and II R–M systems or type IV restric-
tion systems in clinical S. aureus strains could provide a
genetic barrier to the free genetic exchange by transform-
ation, transduction and conjugation (23,24).
A new gene that limits gene transfer was identiﬁed in
two clinical S. aureus strains (SA564 and UAMS-1) (24).
This open reading frame (ORF) contains a super family II
DNA helicase domain and was found to be responsible for
biological restriction of plasmid transformation when
DNA was prepared from E. coli sources and suggested
to be a type III restriction endonuclease based on the
presence of helicase superfamily II domain. Inactivation
of this gene by mutation increased the transformation ef-
ﬁciency by 10
2–10
4-fold. However, no companion methyl-
ase gene was found adjacent to the newly discovered gene,
which is different from the typical gene organization of
type III R–M systems (24). There are three possibilities:
(i) interference with gene transfer operates by a mechan-
ism other than cleavage [abortive infection, for example,
in references (25,26)]; (ii) interference may be due to
site-speciﬁc cleavage of an unmodiﬁed site, with the M
gene located somewhere else on the bacterial chromosome;
or (iii) cleavage may occur but depend on speciﬁc DNA
modiﬁcations such as 5mC, 5hmC, glc-hmC, N6mA,
N4mC or phosphothioation of the DNA backbone (27).
Here, we present experimental evidence that indeed
SauUSI, a gene nearly identical to those found in
S. aureus strains SA564 and UAMS-1, is a modiﬁcation-
dependent REase that requires ATP or dATP for endo-
nuclease activity and that the transformation barrier is
due to cleavage activity of 5mC-modiﬁed DNA. No type
III methylase homolog was found near the SauUSI restric-
tion gene or in the entire sequenced bacterial genome. In
addition, we found that divalent cations are required for
optimal endonuclease activity. We propose that SauUSI
and its homologs are classiﬁed as type IV restriction
systems. To explore the distribution of SauUSI and its
close relatives, we also identiﬁed orthologs of this type
IV restriction gene in other bacterial species, ﬁnding
over 150 candidates. In addition, we demonstrate the bio-
logical relevance of SauUSI in restricting modiﬁed
plasmid DNAs in S. aureus and E. coli during transform-
ations and in phage restriction.
MATERIALS AND METHODS
Bacterial strains, genomic DNA and plasmids
ER2566 (C2566, NEB) is an E. coli B strain with the T7
RNA pol gene (T7 gene 1) integrated into the chromo-
some and deﬁcient in Dcm methylase (Dcm), McrBC
and Mrr. The IMPACT protein expression kit and
pTYB1 vector were obtained from NEB. Unmodiﬁed
(Dcm
 )   phage DNA, pUC19 and pBC4 were prepared
from ER2566. The backbone vector of pBC4 is pUC19
which carries a BstBI/ClaI fragment of adenovirus-2
DNA. T4gt DNA (deﬁcient in a-and b-glucosyl-
transferases, containing 5hmC) was a gift from
R. Vaisvila (NEB).   Dcm
+Dam
 ,   Dcm
+Dam
+ and
pBR322 Dcm
+ DNAs were from NEB. Genomic DNA
of S. aureus subsp. aureus USA300, FPR3757 was
purchased from ATCC. Plasmid DNA was prepared by
Qiagen mini-prep spin columns. Transformations of
S. aureus cells with plasmid DNA were performed as
described in Corvaglia et al. (24).
Protein expression and puriﬁcation
The SauUSIR gene (2859bp, 953aa) ﬂanked by SalI and
XhoI restriction sites was ampliﬁed by polymerase chain
reaction (PCR) using high-ﬁdelity Phusion DNA polymer-
ase (Finnzymes). Following SalI and XhoI restriction di-
gestion, the ampliﬁed DNA was ligated to pTYB1 with
the same cohesive ends. The ligated DNA was transferred
into ER2566 competent cells by transformation. The
inserts in two clones with the highest enzyme activity
were sequenced and found to contain the wild-type (wt)
sequence. For small-scale protein puriﬁcation, 4 L cells of
ER2566 [pTYB1-SauUSIR] were cultured at 37 Ci nL B
supplemented with Amp (100mg/ml) until late log phase.
isopropyl-b-D-thiogalactopyranoside (IPTG) induction
was carried out at 0.5mM ﬁnal concentration and cell
cultures induced at 16 C overnight. Cells were harvested
by low-speed centrifugation, resuspended in a sonication
buffer (20mM Tris–HCl, pH 8.5, 0.5M NaCl, 0.1%
Triton X-100) and lysed by repeated sonication. After cen-
trifugation, clariﬁed cell lysate was loaded onto a chitin
column ( 21ml,  4cm  2.6cm), which was then exten-
sively washed with 10 column volumes of column buffer
(20mM Tris–HCl, pH 8.5, 0.5M NaCl). The column was
then ﬂushed quickly with 20ml of column buffer with
50mM DTT and stored at 4 C overnight to allow the
cleavage of SauUSI from the SauUSI–intein–chitin-
binding domain (CBD) fusion. Approximately 15ml of
proteins (1ml 15) were eluted and analyzed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE). To remove the nucleic acids from the eluted
proteins, the pooled fractions were loaded onto a Source
Q column (GE Healthcare) at 0.25M NaCl concentration.
The ﬂow-through containing the SauUSI protein was
then loaded onto a HiTrap
TM heparin column (GE
Healthcare), and proteins were eluted with a linear
gradient of 50mM to 1M NaCl. After analysis of the
eluted fractions on SDS–PAGE, the fractions with
SauUSI were concentrated in a protein concentrator
(Amicon/Millipore, 10000kDa) by low-speed centrifuga-
tion. The protein was diluted in NEB Diluent A buffer
and stored at  20 C.
To remove the divalent metal ions bound by the puriﬁed
SauUSI, the enzyme was supplemented with 20mM
EDTA and then dialyzed against a buffer (50mM NaCl,
20mM Tris–HCl, pH 8, 1mM DTT) for 48h at 4 C using
a dialysis cassette (10000Da MWCO; Thermo Scientiﬁc
Pierce).
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chitin beads, 10ml of cells were cultured to late log phase
at 37 C. After addition of 0.5mM IPTG (ﬁnal concentra-
tion), SauUSI protein expression was induced at 16 C
overnight. Cell pellets were resuspended in 1ml of cell
lysis buffer (20mM Tris–HCl, pH 8.5, 0.5M NaCl,
0.1% Triton X-100), and cells were lysed by sonication.
Clariﬁed cell lysates were mixed with 200ml of chitin beads
prewashed with column buffer (20mM Tris–HCl, pH 8.5,
0.5M NaCl) and gently mixed on a rocker at 4 C for 1h.
Chitin beads with bound proteins were spun down at low
speed centrifugation and washed three times with 1.5ml
of column buffer. The chitin beads were then resuspended
in cleavage buffer (20mM Tris–HCl, pH 8.5, 0.5M NaCl,
50mM DTT) and incubated at 4 C overnight. The super-
natants containing SauUSI variants were analyzed on
SDS–PAGE and assayed for cleavage activity on T4gt
DNA.
For constitutive expression of SauUSI endonuclease
gene (sauUSIR)i nE. coli, a PCR fragment with re-
engineered ribosome binding site (GGATCC-GGAGGT-
AAATGA-start codon) was cloned into the BamHI site of
pBR322 under the Tc
R promoter. As a control, the
sauUSIR gene inserted in the opposite orientation was
also constructed.
Site-directed mutagenesis
The catalytic residues H119, K121, N139 and E150 of
SauUSI endonuclease were mutated to alanine (Ala) by
two-step overlapping PCR using Phusion
TM high-ﬁdelity
DNA polymerase 2x master mix (Finnzymes). Full-length
ampliﬁed DNAs, following DpnI, SalI and XhoI diges-
tion, were gel-puriﬁed and ligated to pTYB1 with compat-
ible ends. Desired mutations were conﬁrmed by DNA
sequencing. For small-scale afﬁnity puriﬁcation, cell
extracts from 10ml IPTG-induced overnight culture
(16 C) were used for batch puriﬁcation of the mutant
enzymes. For medium-scale puriﬁcation, cell lysates of
1 L IPTG-induced overnight cell cultures (16 C) were
used for chitin column puriﬁcation. Partially puriﬁed
SauUSI variant H119A was used for gel ﬁltration chro-
matography to determine its oligomerization state in NEB
buffer 4.
SauUSI digestion and in vitro DNA methylation
SauUSI digestions of various DNA substrates were
carried out at 37 C in NEB buffer 4, except speciﬁed
otherwise. To study the cofactor requirement of SauUSI
endonuclease activity, EDTA-treated and extensively
dialyzed SauUSI enzyme was incubated with DNA sub-
strates in reaction buffers containing different divalent
cations (1 and 5mM of Mg
+ +,M n
+ +,C a
+ +,C o
+ +,Z n
+ +
or Ni
+ +). To understand the NTP or dNTP requirement
for the SauUSI enzyme activity, reactions were supple-
mented with 1mM ATP, g-S-ATP (from Sigma–
Aldrich), GTP, g-S-GTP (from Sigma Aldrich), UTP
(from Roch Applied Science), dATP, dCTP, dGTP or
dTTP. For in vitro DNA modiﬁcation study, unmodiﬁed
pBC4 plasmid DNA (Dcm
 ) was modiﬁed by M.MspI
(modiﬁed base as underlined 5mCCGG), M.HpaII
(C5mCGG), M.HhaI (G5mCGC), M.AluI (AG5mCT),
M.BamHI (GGAT4mCC) and M.TaqI (TCG6mA), re-
spectively, in the recommended 1x methylation buffers
with S-adenosylmethionine (SAM) at 37 C for 2h.
Methylated plasmid DNAs were puriﬁed by spin columns
and used as the substrates for SauUSI digestion.
5mC- or 5hmC-modiﬁed PCR DNAs with S5mCNGS
sites (1, 2, 4, 5 and 6 sites) were produced in PCRs with
5mC (5m-dCTP) or 5hmC (5hm-dCTP) instead of dCTP.
The small amount of unmodiﬁed template DNA (<0.1ng/
ml) did not interfere with SauUSI digestion and cleavage
site determination. SauUSI-digested PCR DNAs were
puriﬁed by spin columns using a PCR puriﬁcation kit
(Qiagen) and run-off sequencing was carried out using a
Big-Dye

terminator cycle sequencing kit (ABI/Life tech-
nologies). Similarly, after digestion of pBR-fnu4HIM
(G5mCNGC) plasmid by SauUSI endonuclease, the
digested DNA was puriﬁed by spin column and used as
template for run-off sequencing to determine the cleavage
sites.
Gel ﬁltration study of SauUSI H119A variant
Ten microliters of puriﬁed SauUSI variant H119A (1mg/
ml) was injected into a Superdex 200 5/150 GL (3ml bed
volume; GE Healthcare). The column was run with NEB
buffer 4 at 4 C at a ﬂow rate of 0.2ml/min. The partition
coefﬁcient (Kav) of SauUSI-H119Awas determined by
Kav=(ve – vo)/(vt – vo) where ve is the elution volume, vo
is the void volume of the column and vt is the total column
volume. vo and vt were determined empirically by the
addition of blue dextran and DTT, respectively to the
sample. A standard curve was created by obtaining the
Kav value of the standard proteins ovalbumin (43kDa),
conalbumin (75kDa) and ferritin (440kDa) (GE
Healthcare) run under the same condition.
Phage plating and restriction of phage by SauUSI
Dcm
+  vir (a gift from A. Fomenkov, Mern Sibley,
Lise Raleigh) was prepared from E. coli host ER1793.
EcoK Dcm methylase modiﬁes the DNA sequence
CCWGG to produce modiﬁed sites C5mCWGG
(W=A or T). Dcm
   vir was prepared from ER2566, a
natural Dcm-deﬁcient B strain. T4gt phage containing
5hmC was prepared from ER2566. Phages were diluted
in phage broth or 10mM MgCl2 solution and used to
infect the E. coli hosts.
RESULTS AND DISCUSSION
SauUSI expression and puriﬁcation
The sauUSIR gene was ampliﬁed from genomic DNA of
S. aureus subsp. aureus USA300, FPR3757, and inserted
into the T7 expression vector pTYB1. This results in a
fusion of the ORF to the Sce VMA intein and Bacillus
circulans CBD (IMPACT protein puriﬁcation system,
NEB). IPTG-induced ER2566 cell extracts showed endo-
nuclease activity on   DNA (Dcm
+) in the presence of
ATP and 10mM DTT (data not shown). Two clones
with the correct-sized insert and the highest endonuclease
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A small-scale puriﬁcation procedure was developed.
SauUSI was ﬁrst puriﬁed from a chitin column using the
DTT-intein cleavage mechanism recommended by the
manufacturer. The cleaved and eluted fractions were
passed through a Source Q column at moderate salt con-
centration to remove most of the nucleic acids. The
ﬂow-through was then loaded onto a HiTrap
TM heparin
column and protein eluted with a NaCl gradient. The puri-
ﬁcation results are shown in Supplementary Figure S1.
Two heparin fractions with the highest purity
(Supplementary Figure S1, lanes 5 and 6) were concen-
trated to 0.2mg/ml and used for further characterization.
SauUSI substrate speciﬁcity
Since SauUSI contains a helicase domain and ATP-
binding site (inferred from amino acid sequence similarity
to other type I and III REases), we included ATP (1mM)
in all digestions (see below for further data on nucleotide
requirement). Figure 1A shows that SauUSI cleaves
5hmC-containing T4gt DNA as well as 5mC-containing
DNA from a variety of sources: Dcm-modiﬁed   and
pBC4 DNA (pBC4 is a pUC19 derivative carrying a
BstBI/ClaI fragment insert from adenovirus DNA),
HeLa and Jurkat genomic DNA (human). Escherichia
coli Dcm modiﬁes CC(A/T)GG sequences at the internal
cytosine, while mammalian DNA carries methylation in
some CpG sites. Dam modiﬁcation does not inhibit
cleavage since both Dam
+ and Dam
    DNA were
equally cleavable by SauUSI (Figure 1A, lanes 3 and 4).
SauUSI displays lower cleavage activity on 5-glc-hmC
DNA (glucosylated T4 DNA, wild type) (Figure 1A,
lane 1).Unmodiﬁed (Dcm
 ) pBC4 is a poor substrate for
SauUSI although a small fraction of DNA was partially
linearized (Figure 1A, lane 5), which suggests that SauUSI
has a non-speciﬁc endonuclease activity at high enzyme
concentration, or that there is a low level of contaminating
non-speciﬁc nuclease. The 0.4–0.5-kb DNA of T4gt di-
gested products was an artifact which dispersed in high
percentage agarose gel or PAGE (data not shown).
Figure 1B shows the undigested DNA substrates.
SauUSI also displays very low endonuclease activity on
Dam
+ Dcm
  pUC19 and pBR322 DNAs (data not
shown). The speciﬁc activity of SauUSI is determined to
be  8000 U/mg protein on T4gt phage DNA in the
presence of ATP. One unit of SauUSI is deﬁned as the
amount of enzyme required to digest 1mg T4gt DNA into
fragments of <500bp in NEB buffer 4 at 37 C for 1h.
Figure 1. SauUSI digestion of modiﬁed and unmodiﬁed DNA substrates. (A) DNA substrates digested by SauUSI endonuclease in 1X NEB buffer 4
at 37 C for 1h. (B) Uncleaved DNA substrates. T4 wt DNA contains glucosylated 5-hmC DNA. T4gt deﬁcient in a- and b-glucosyl transfereases
contains 5hmC DNA. Lane 9, 2-log DNA size marker. (C) SauUSI digestion of in vitro modiﬁed DNA. Plasmid pBC4 was methylated in vitro by the
indicated methyltransferase and subsequently digested by SauUSI. Lane 7, mock-modiﬁed pBC4 DNA (Dcm
 ) (only SAM was present, no
methylase). Lane 8, in vivo modiﬁed pBC4 (Dcm
+). (D) In vitro methylated DNA (uncleaved) of the same substrates as in (C).
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Dcm
  plasmid pBC4 substrates were modiﬁed in vitro
by puriﬁed methylases and then used as substrates for
SauUSI digestion. Figure 1C shows that SauUSI cleaves
pBC4 plasmid after in vitro modiﬁcation by M.MspI
(5mCCGG), M.HpaII (C5mCGG), M.HhaI (G5mCGC)
or M.AluI (AG5mCT). Modiﬁed pBC4 DNAs by M.SssI
(5mCG) or M.CviPI (G5mC) also allowed partial cleavage
by SauUSI (data not shown). N4mC modiﬁed DNA by
M.BamHI (GGATm4CC) or N6mA modiﬁed by M.TaqI
(TCG6mA) are poor substrates for SauUSI (Figure 1C,
lanes 4 and 7). Dcm
+ pBC4 (C5mCWGG site modiﬁed
in vivo) was again cleaved by SauUSI. In summary,
SauUSI appears to cleave when 5mC is present in the
following 30 sequence contexts: 5mCC, 5mCG, 5mCT
and 5mCW (see more sequence requirement below).
SauUSI does not cleave N4mC and N6mA-modiﬁed
DNA (the Dcm
- substrates do carry adenine modiﬁcation
in the G6mATC context). This 5mC/hmC-dependent sub-
strate speciﬁcity is shared by McrBC, although McrBC
activity requires GTP hydrolysis. The digestion pattern,
appearing as a ‘smeargram’, suggests non-speciﬁc
nuclease activity (or strong ‘star’ activity) following
incision from (or near) the modiﬁed 5mC/5hmC sites.
The non-speciﬁc nuclease activity might be important to
completely destroy the foreign invading DNA (the
cleavage products are not easily repaired by simple
religation).
We also tested SauUSI digestion of plasmids that have
been modiﬁed in vivo by C5 methylases. Methylase gene-
containing plasmids were co-transformed with pBC4 into
a Dcm-deﬁcient host ER2566 and plasmid mixture was
prepared and digested with SauUSI in the presence
of ATP. All plasmids were found to be mostly resistant
to their cognate REases, and thus modiﬁcations appear
to be complete. The methyltransferases with known modi-
ﬁcations that are sensitive to cleavage are M.EagI
(CCG5mCCG), M.Fnu4HI (G5mCNGC, conﬁrmed
substrate for BisI cleavage) (9), M.BbvI (G5mCAGC,
complement strand G5mCTGC) and M.TspRI
(5mCASTG). Less sensitive to SauUSI cleavage are
M.AclI (AA5mCGTT), M.HpyCH4IV (A5mCGT) and
M.NspHI (R5mCATGY). Other methylases are highly
likely to create 5mC, but the speciﬁc site of modiﬁcation
is not conclusively known. Those that are sensitive to
cleavage are M.BssKI (C5mCNGG or 5mCCNGG),
M.TseI (G5mCWGC) and M.BsrFI (RC5mCGGY)
(Figure 2A). Surprisingly, some methylases with known
5mC modiﬁcation are nearly resistant. These are M.SacI
(GAG5mCTC), M1.BsrDI and M2.BsrDI (G5mCAATG
or 5mCATTGC) (Figure 2A). The resistance of
bsrDIM1M2-containing plasmids to BsrDI digestion
(Figure 2A, lane 20) indicates full modiﬁcation of BsrDI
sites on pBC4. Therefore, incomplete modiﬁcation does
not explain resistance to SauUSI cleavage. Figure 2B
shows undigested plasmid DNAs.
We also tested a number of N4mC-modiﬁed plasmids
in SauUSI digestion. Plasmids carrying N4mC
methylase genes pspGIM, cviSIIIM, TCGA-N4mC
methylase (M.TaqI isoschizomer clone from environmen-
tal samples, Richard Morgan, unpublished data), bstYIM
and bamHIM were poorly digested by SauUSI (Figure
2C), indicating N4mC-modiﬁed DNAs are not good sub-
strates for SauUSI. In a control experiment, Dcm
+
plasmid pXbaI was cleaved by SauUSI.
The substrate speciﬁcity of the in vitro and in vivo
modiﬁed DNA is listed in Table 1. The relative activity
of SauUSI is summarized as follows: S5mCNGS
(M.Fnu4HI, M.BssKI, M.Msp, M.Dcm)>G5mCTC
(M.SacI), A5mCGT (M.HpyCH4IV) >> 5mCAAT or
5mCATT (M.BsrDI). The best in vitro DNA substrates
are T4gt, pBR-fnu4HIM (G5mCNGC) and pACYC-
bssKIM (C5mCNGG), which may reﬂect the frequency
of the modiﬁed sites. For the limited number of N4mC-
modiﬁed plasmids that have been tested, SauUSI endo-
nuclease does not appear to cleave modiﬁed N4mC
DNA efﬁciently.
The density of the 5mC-modiﬁed sites also appears to
inﬂuence SauUSI endonuclease activity. Dcm
+ pBR322
or pBC4 additionally modiﬁed in vitro by M.MspI
(5mCCGG) serves as a better substrate for SauUSI diges-
tion than Dcm
+ modiﬁed alone (data not shown). The
recognition sequence of SauUSI is therefore somewhat
similar to BisI (G5mC/NGC) and BlsI (G5mCN/GC)
(9). The enzymes are distinct, however: SauUSI cleaves
DNA outside of its recognition sequence (see below) and
requires ATP or dATP cofactor. Both enzymes require
divalent cations, but ATP does not stimulate BisI
activity (Priscilla Hiu-Mei Too and Shuang-yong Xu,
unpublished data). In addition, the molecular mass of
the puriﬁed BisI endonuclease was estimated to be
 21kDa (±2kDa) and the apparent molecular mass of
SauUSI is  100kDa.
ATP and dATP requirement for endonuclease activity
Based on BlastP and amino acid sequence alignment (28)
SauUSI contains a predicted ATP binding and DNA
helicase domain in the middle part of the protein (approxi-
mately at 201–625aa). To characterize the presumed nu-
cleotide requirement, we tested SauUSI activity on T4gt
DNA using different NTP or dNTP in the digestion.
Figure 3A shows that only ATP or dATP supports
SauUSI endonuclease activity. A non-hydrolyzable ATP
analog, g-S-ATP, does not support SauUSI endonucle-
ase activity, suggesting ATP hydrolysis is necessary for
the catalytic reaction. To determine the optimal ATP
concentration supporting SauUSI digestion, we tested
SauUSI activity at ATP concentrations in the range of
0.2–20mM on T4gt DNA. SauUSI is optimally active
between 1 and 2mM ATP, with activity detectable
between 0.2 and 12mM ATP under the conditions tested
(1mg T4gt DNA, 1mg SauUSI, in 50ml total digestion
volume) (Figure 3B). The intracellular ATP concentration
was estimated at 2.6mM when E. coli was grown in
culture media (29). No data on intracellular ATP concen-
tration were available for S. aureus USA300 strain. The
biological relevance of the preference of ATP/dATP
over GTP is not clear. It might be advantageous not
competing for the same cofactor if SauUSI-like and
McrBC-like type IV restriction systems co-exist in the
same bacterium.
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The N-terminus of SauUSI contains a phopholipase D
(PLD) family endonuclease catalytic site (the HKD cata-
lytic motif, approximately at 1–200aa) (30). Some PLD
family nucleases are active in the absence of divalent metal
ions (in the presence of EDTA) (31,32). We therefore
evaluated whether SauUSI requires divalent metal ions
for optimal activity. SauUSI is active in the four NEB
buffers, all of which contain 10 mM Mg
+ + (before
EDTA treatment and dialysis), with highest activity in
buffer 4 (50mM potassium acetate). It is also active at
NaCl concentrations of 50, 100, 150 or 200mM with
10mM MgCl2 (Figure 4A, lanes 2 and 3, 5 and 6).
SauUSI is partially active in a buffer in the absence of
additional metal ions (50mM NaCl, 10mM Tris–HCl,
pH 8, 1mM DTT) as shown in Figure 4A, lane 8, but
addition of 10mM EDTA completely inhibited endo-
nuclease activity (Figure 4A, lane 7). To clarify the
nature of the requirement, we prepared enzyme depleted
of EDTA-chelatable divalent cations. A volume of 20mM
EDTA was added into the SauUI enzyme, which was then
dialyzed into a new buffer for 48h. The metal ion-depleted
SauUSI was retested for enzyme activity in buffer with or
without divalent cations. Figure 4A, lane 9 shows that
SauUSI is inactive after EDTA treatment and the subse-
quent extensive dialysis. The metal ion-depleted SauUSI
regained activity in buffer 4 with Mg
+ +, and its activity
was again inhibited if EDTA was added (Figure 4A, lanes
10 and 11). It is not clear whether the metal ion is required
for the endonuclease activity or for the ATPase activity or
for both. Further experiments are needed to uncouple the
two reactions.
We also supplemented the depleted enzyme preparation
with Mn
+ +,C a
+ +,C o
+ +,Z n
+ +,N i
+ + or Cu
+ +, ﬁnding
partial activity in buffers with 1mM Mn
+ +,C a
+ + or
Co
+ +. The relative endonuclease activity in different
metal ions are Mg
+ +>Mn
+ + > Ca
+ +>Co
+ + (data not
Figure 2. SauUSI digestion of 5mC-modiﬁed plasmid DNAs. (A) Plasmids prepared from co-transformants of pACYC-M (or pSYX20-M) and
pBC4 were digested by SauUSI for 1h at 37 C and the digested DNAs were analyzed on a 1% agarose gel. Lanes 1–3, unmodiﬁed DNA digested by
SauUSI. Lane 4, Dcm-modifed pBC4 digested by SauUSI. Lanes 5, 6, 8–11, 13–17, 19, modiﬁed plasmid mixture (plasmid with M gene plus pBC4)
digested by SauUSI. Lane 7, M.BbvI-modiﬁed plasmid pUC-bbvIM; lane 18, M.TspRI-modiﬁed plasmid pUC-tspRIM (M gene under native
Thermus promoter). Lane 20, M.BsrDI modiﬁed plasmids digested by BsrDI (note: resistance to BsrDI digestion indicates BsrDI site modiﬁcation).
Lane 22, uncut pBC4 plasmid DNA. Lanes 12 and 23, 2-log DNA size ladder. Duplicated DNA samples: lane 5, pACYC-aclIM; lane 6, pSYX20-
aclIM; lane 17, pACYC-tspRIM; lane 18, pUC-tspRIM (M gene under Thermus sp. native promoter). (B) Undigested plasmids carrying 5mC
methylase genes. Lane 2, pUC-bbvIM; lane 7, pBR-fnu4HIM. Lanes 1, 3–6, 8–12, plasmid with the indicated M gene and pBC4 mixture.
(C) SauUSI digestion of N4mC-modiﬁed plasmid DNAs. Plasmid pXbaI was puriﬁed from a Dcm
+ strain (5mC-modiﬁed control DNA).
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Zn
+ +,N i
+ +or Cu
+ +(1–5mM, data not shown). The pro-
miscuous use of metal ions for SauUSI activity may pro-
vide certain advantage in restricting phage or plasmid
DNA if one or two cofactors are in limited supply under
certain growth condition. It was interesting to note that
glc-hmC-speciﬁc endonuclease GmrSD prefers Ca
+ +metal
ion and UTP for optimal activity (15), ScoMcrA prefers
Mn
+ + and Co
+ + for endonuclease activity (33) and
HpyAV, an HNH-type endonuclease, prefers Ni
+ + for
activity (34).
Mixing of unmodiﬁed pUC19 DNA with Dcm
+ j (m5C)
DNA or T4gt (5hmC) DNA in SauUSI digestion
In principle, SauUSI could have a cryptic endonuclease
activity that is activated upon recognition of modiﬁed
DNA. If so, activation might allow action in trans on a
separate unmodiﬁed molecule. We ﬁnd, however, that it
acts on 5mC/hmC-modiﬁed DNA only in cis. The endo-
nuclease catalytic activity is tightly coupled with 5mC or
5hmC recognition. This was demonstrated with a mixing
experiment. We mixed unmodiﬁed and modiﬁed DNA
and digested the mixture with SauUSI. Dam
+ Dcm
 
pUC19 DNA was poorly digested when it was mixed
with   DNA (Dcm
+) or T4gt (5hmC) DNA, while  
DNA (Dcm
+) or T4gt (5hmC) DNA was preferen-
tially cleaved by SauUSI in the two-DNA mixtures
(Figure 4B, lanes 1–4). A small fraction of the unmodiﬁed
pUC19 DNA (Dcm
 ) was linearized and nicked by
SauUSI endonuclease (see also above). As expected,
Dcm
+ pUC19 was digested by SauUSI (Figure 4B, lane
6). Similarly, HindIII-digested pUC19 DNA (Dcm
 ) was
not digested when it was mixed with modiﬁed   (Dcm
+)o r
T4gt (5hmC) DNA or mixed with duplex oligos contain-
ing two C5mCGG-modiﬁed sites (data not shown). This
inactivity toward unmodiﬁed DNA is important since the
native host DNA (self DNA) is presumably not methyl-
ated at position 5 of the cytosine (N4mC does not appear
to matter). Inspection of the sequenced genome of
S. aureus subsp. aureus USA300 does not ﬁnd any candi-
date 5mC methylases (two putative Type I N6mA
methylases are present, data now shown), consistent
with the notion that this type IV enzyme has been evolved
to selectively restrict foreign-modiﬁed 5mC/5hmC DNA.
We changed the classiﬁcation of SauUSI-like restriction
enzymes from type III (24) to type IV, reﬂecting the
fact that SauUSI is a modiﬁcation-dependent REase,
and that the SauUSI-like REase in S. aureus clinical
strain SA564 only restricts 5mC-modiﬁed plasmid DNA
(see below). On the other hand, SauUSI could also be
considered as a type IIM enzyme under certain circum-
stances since its cleavage of short duplex oligos are rela-
tively precise, 2–3nt outside of its recognition sequence
(see below).
Supplementary Figure S2 shows a time course of limited
digestion by SauUSI in digesting M.EagI-modiﬁed
plasmid mixture (pACYC-eagIM and pBC4). Early in
the reaction (2–6min), intermediate DNAs (probably in
linear form) were detected. After 20min digestion, only
a smearing pattern was observed. It is likely that the
SauUSI endonuclease binds to the M.EagI-modiﬁed sites
and makes cleavage/nicks on both strands, and may
continue digestion along the modiﬁed molecules in cis
using the DNA helicase activity. SauUSI displays a
strong nuclease activity on single-stranded DNA.
However, this nuclease activity is not modiﬁcation de-
pendent (data not shown).
Digestion of 5mC-containing PCR DNA substrates and
run-off sequencing of the cleavage products
A  430-bp fragment of pACYC184 between the BamHI
and SalI site that contains six SCNGS sites was generated
by PCR ampliﬁcation using 5m-dCTP or regular dCTP.
The 5mC-containing PCR product was apparently
digested by SauUSI endonuclease, generating a mixture
of discrete bands and smearing (Figure 5A). The digestion
was incomplete because many of the bands are bigger than
the predicted cleavage products of 5mCCGG, C5mCGG,
G5mCNGC, C5mCNGG or C5mCWGG generated by
virtual digestion using the NEB cutter (http://tools.neb.
com/NEBcutter2/). In contrast, the PCR product made
using regular dCTP was only much less cleaved at the
same enzyme concentrations, conﬁrming the preference
of SauUSI to 5mC-modiﬁed DNA (Figure 5A).
Similarly, we generated a single site (GCCGC) 73-bp
PCR fragment in PCR from pBR322 template and used
it as a substrate for SauUSI digestion. The single-site PCR
DNA was not cleaved by SauUSI (Figure 5B, lane 2). A
two-site PCR substrate (GCTGC and GCAGG) with a
length of 90bp was cleaved by SauUSI; and another
two-site substrate (GCGGG, GCCGC) with 99bp long
was also sensitive to SauUSI digestion (Figure 5B, lanes
4 and 6). Longer 5mC-containing PCR products with 5
Table 1. Digestion of 5mC-modiﬁed plasmid DNAs by SauUSI
C5 methylase In vivo/in vitro
modiﬁcation
Modiﬁed
sites
Relative
endonuclease
activity
M.HpaII In vitro CCGG + +
M.MspI In vitro C CGG + +
M.EagI In vivo CGG C CG + +
M.BssKI In vivo CCNGG (?)+ + +
M.BsrFI In vivo RC C GGY (?)+ +
M.BbvI In vivo GCAGC + +
M.Fnu4HI In vivo GCNGC + + +
M.Dcm In vivo CCWGG + +
M.TseI In vivo GCWGC + +
Consensus sequence SCNGS
M.HhaI In vitro GCGC + +
M.SssI In vivo or in vitro C G +
M.AclI In vivo AA C GTT +
M.HpyCH4IV In vivo ACGT +
M.AluI In vitro AG C T + +
M.NspHI In vivo RCATGY +
M.TspRI In vivo C ASTG +
M.SacI In vivo GAG C TC (?) +/–
M1.BsrDI In vivo GCAATG –
M2.BsrDI In vivo C ATTGC –
(?) indicates possible modiﬁed cytosine; ‘‘+/–’’ indicates poor activity;
‘‘––’’ denotes no apparent activity in 1h digestion, underlined C indi-
cates modiﬁed base. R=A/G; S=G/C; W=A/T. The best-modiﬁed
substrates are G5mCNGC (M.Fnu4HI) and C5mCNGG (M.BssKI).
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partially cleaved products were detected (Figure 5B, lanes
8 and 10). Similar results were obtained with 5hmC-
containing PCR DNAs. A single site (GCCGC) with
5hmC incorporated in PCR was a poor substrate for
SauUSI digestion (Figure 5C), whereas 5hmC-containing
PCR DNA with four SauUSI sites were cleavable by
SauUSI (Figure 5D). 5hmC-containing PCR DNA with
two sites was also cleaved by SauUSI (data not shown).
Run-off sequencing from the digested PCR products indi-
cates that SauUSI cleaves DNA 2–3bp outside of its rec-
ognition sequence GCCGC/GCGGC. There are three
types of cleavage detected by run-off sequencing. Primer
F210 detected two breaks (two double peaks) at the 30 side
of GCGGC recognition site (Supplementary Figure S3,
bottom panel) in comparison with undigested pBR322
sequence (top panel) (the cut site distance can be inter-
preted differently considering the overlapping GCCGC
site). Primer F571 detected two breaks (two double
peaks) from the 50 side of GCGGC/GCCGC target site
(Supplementary Figure S4, bottom panel) compared to the
control DNA sequence using the same primer. Primer
F670 detected multiple DNA breaks/double peaks
(Supplementary Figure S5), cleavage possibly taking
place 3-bp 50 and 30 of the GCGGC/GCGGC target site,
and another possible cut at 13bp upstream (one DNA
helical turn apart), implying that SauUSI is capable of
sliding and cutting at long distance.
We also analyzed the cleavage sites of 5mC-modiﬁed
plasmid DNA. The fnu4HIM gene was cloned in
pBR322 and its expression was driven by the Tc
R
promoter. The plasmid DNA pBR322-fnu4HIM extracted
form overnight culture was fully resistant to Fnu4HI di-
gestion (data not shown). Following digestion of pBR322-
fnu4HIM by SauUSI for 2h, the digested DNA was
puriﬁed and subjected to run-off sequencing.
Supplementary Figure S6 (bottom panel) shows that
SauUSI cleaves outside of recognition sequence at N3,
N10 and N14–18, with complete run-off at N18 from the
target site, indicating SauUSI’s ability to travel and
cleave at long distance from the G5mCCGC site.
Supplementary Figure S6 (top panel) shows the DNA
sequencing result from uncut pBR322 DNA. More
cleavage sites remain to be analyzed in order to get a
complete picture of SauUSI cut sites. The preliminary
results indicate that SauUSI endonuclease is most likely
Figure 3. SauUSI digestion of plasmid and T4gt DNAs in the presence of NTP or dNTP. (A) Plasmid DNAs were digested by SauUSI in the
presence of NTP or dNTP as indicated. Lanes 1–10, digestion of modiﬁed DNA pBC4 (Dcm
+). Lane 11, unmodiﬁed pBC4 (Dcm
 ) plus ATP and
SauUSI. (B) T4gt DNA was digested by SauUSI at various ATP concentrations (0.2–20mM).
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short PCR DNA ( 90–200bp). For the M.Fnu4HI-
modiﬁed plasmid DNA ( 6kb), the SauUSI cleavage
sites vary from N3 to N18 (G5mCNGC N3–18, bottom
strand). It would be interesting to engineer SauUSI
variants to cleave at longer distance at the ﬁxed position.
Site-directed mutagenesis of catalytic residues of
SauUSI endonuclease
The H119 and K121 residues in SauUSI are highly
conserved among PLD family endonucleases; and the
N139 and E150 residues are somewhat conserved (N, D,
Q, E are sometimes interchangeable at the two positions).
We mutated H119, K121, N139 and E150 to Ala by site-
directed mutagenesis and partially puriﬁed the mutant
proteins. Figure 6A shows the puriﬁed variant proteins.
The mutant protein yields are 4–5-fold higher than the wt
enzyme, probably reﬂecting the reduced toxicity of the
mutant endonucleases toward the E. coli expression
host. The mutant enzyme variants are inactive in digestion
of 5hmC T4gt DNA (Figure 6B, lanes 1–8). In contrast,
the wt enzyme (batch-puriﬁed SauUSI in lanes 9 and 10,
and column-puriﬁed SauUSI in lane 11) is active in
cleaving T4gt DNA. This mutagenesis experiment con-
ﬁrmed the prediction that H119, K121, N139 and E150
are involved in catalytic activity. Mutations of these four
catalytic residues to Ala abolished the endonuclease
activity.
Oligomerization state of variant H119A
The oligomerization state of SauUSI was investigated
using gel-ﬁltration chromatography on an analytical
Figure 4. Digestion of T4gt by SauUSI in NEB buffers 1–4, in the presence of EDTA, or in the absence of metal ions (depleted from enzyme
preparation). (A) Lanes 1–4, SauUSI digestion in NEB buffers 1 to 4. Lanes 5 and 6, 150 and 200mM NaCl in a buffer containing 20mM Tris–HCl,
pH 8.0, 1mM DTT, 10mM MgCl2. Lane 7, SauUSI digestion in the NTD buffer (50mM NaCl, 20mM Tris–HCl, pH 8.0, 1mM DTT), plus 10mM
EDTA. Lane 8, same as lane 7, except EDTA was left out, no additional metal ions were added to the buffer. Lane 9, T4gt DNA incubated with
metal ion-depleted SauUSI in the NTD buffer without additional metal ions. Lane 10, T4gt DNA digested with metal ion-depleted SauUSI in buffer
4. Lane 11, same as lane 10, but supplemented with 10mM EDTA. (B) SauUSI digestion of modiﬁed DNA mixed with unmodiﬁed DNA. Lanes 1–6,
SauUSI digestion of DNAs. The ‘‘–’’ and ‘‘+’’ on top of pUC indicate unmodiﬁed or modiﬁed pUC19 by Dcm methylase, respectively. Lane 11,
DpnI digestion of pUC19.
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SauUSI H119A was compared to those of standard
proteins to obtain the relative molecular weight (Mr).
The elution proﬁle of SauUSI H119A from two separate
runs contains a single peak with Mr of 76kDa (open
circles; Figure 7). The absence of peaks that correspond
to oligomers of SauUSI indicates that SauUSI exists most
likely as monomers in solution in the absence of target
DNA. The physical properties of SauUSI enzyme with
speciﬁc and non-speciﬁc DNAs remain to be analyzed.
Restriction of phage by SauUSI endonuclease
The biological function of type IV restriction systems is to
restrict modiﬁed foreign DNA (phage or plasmid) (35,15).
We tested the restriction of phages by SauUSI endonucle-
ase using Dcm
+or Dcm
    phages that have been grown
on modiﬁcation proﬁcient or deﬁcient E. coli hosts. The
plating efﬁciency of Dcm
+   phages is 0.03–0.04% (two
independent experiments) on a SauUSI-containing host,
compared to the high efﬁciency on host containing empty
vector (Table 2). As expected, SauUSI does not restrict
unmodiﬁed Dcm
    phages. A frame-shift mutant of
SauUSI (a single base deletion at nt positon 85) abolished
the ability to restrict Dcm-modiﬁed   phages. The deletion
mutant (frame-shift mutant) was found during screening
of sauUSIR gene insert in pBR322.
In vivo DNA restriction activity of S. aureus clinical
strain SA564 and its restriction-deﬁcient counterpart
Due to the possible existence of other active type I and
type IV restriction systems in the S. aureus USA300 strain,
we tested the possibility of this type IV (referred to as type
III-like in Corvaglia et al., 2010) restriction system re-
stricting methylated DNA in vivo, using S. aureus
clinical strain SA564. We measured the transformation
efﬁciencies of plasmid prepared from different E. coli
strains. We used strains deﬁcient in adenine methylation
(dam
 ), deﬁcient in cytosine methylation (dcm
 ), a double
Figure 5. SauUSI digestion of 5mC- or 5hmC-containing PCR DNA. (A) Sixty nanograms of a 436-bp substrate DNA was digested with 1, 0.5 and
0.25mg of SauUSI REase in NEB Buffer 4 with 1mM ATP for 2h at 37 C (lanes 1, 2, 3 and 5, 6, 7, respectively). The substrate in lanes 1–4 was
made in PCR using 5m-dCTP. The substrate in lanes 5–8 was made in PCR using regular dCTP. The reactions were analyzed using a 5% TopVision
gel (Fermentas) stained with SYBR Gold (Invitrogen). (B) SauUSI digestion of 5mC-containing PCR DNAs (73bp-1 site, 90bp-2 sites, 99bp-2 sites,
260bp-5 sites and 198bp-4 sites, respectively). PCR substrates were digested by SauUSI for at 37 C for 2h and the enzyme was inactivated at 65 C
for 20min. DNA fragments were resolved in a 15% PAGE-Urea gel (Invitrogen) and stained with SYBR Gold. LM, low molecular DNA marker;
10bp, 10bp DNA ladder. (C) SauUSI digestion of dC-, 5mC-, 5hmC-containing PCR DNA (73bp-1 site): 100bp, 100bp DNA ladder. DNA was
subjected to 2.5% agarose gel electrophoresis. (D) SauUSI digestion of dC-, 5mC-, 5hmC-containing PCR DNA (207bp-4 sites). Two enzyme
concentrations were used in the digestion. DNA fragments were resolved in 2.5% agarose gel electrophoresis.
5606 Nucleic Acids Research, 2011,Vol.39, No. 13mutant (dam
  dcm
 ), or wild-type (wt, dam
+dcm
+DH5a)
for both methylation systems. To exclude problems in
transformation efﬁciency other than the restriction of
the plasmid DNA, we also prepared plasmid DNA from
RN4220, the permissive laboratory S. aureus strain.
We have previously shown that plasmid DNA from
RN4220 can efﬁciently be transformed into SA564, inde-
pendent of the presence or absence of the two restriction
systems. Mixtures of plasmids prepared from E. coli and
S. aureus were transformed into the clinical strain SA564
and its restriction-deﬁcient counterpart (SA564 hsdR::
targetron/type I-deﬁcient, type IV-like::targetron/deﬁcient
in SauUSI-like REase) (24). The results presented in
Table 3 show that the transformation efﬁciency of
Dcm
+-modiﬁed DNA is reduced by more than three-order
of magnitude in wt SA564 strain. In contrast, plasmid
DNA prepared from dcm-deﬁcient strains efﬁciently trans-
formed wild-type and mutant SA564 strains. In compari-
son, the absence of dam methylation did not inﬂuence the
transformation efﬁciency. These results clearly show that
this new restriction system recognizes C-methylated DNA
and restricts only Dcm
+-modiﬁed DNA in vivo.
In vivo restriction (toxicity) by constitutive expression of
SauUSI endonuclease in Dcm
+ E. coli
Initially, we tested plasmid DNA transformation of
pTYB1-sauUSIR into Dcm
+ or Dcm
  E. coli strains.
The transformation efﬁciency of pTYB1-sauUSIR into a
Dcm
+strain is only 5–10-fold lower than the empty vector
pTYB1 (data not shown). We attributed this low level of
restriction to the low expression level of SauUSI from
pTYB1 in E. coli under non-inducing condition (or poor
in vivo cleavage of the fusion protein SauUSI-intein-CBD
to produce active SauUSI). To circumvent this problem,
we recloned the sauUSIR gene into pBR322 with an
optimal ribosome binding site using a dcm-deﬁcient host
so that the sauUSIR gene is constitutively expressed under
the Tc
R promoter. Another clone with the sauUSIR
gene inserted in the opposite orientation was also
Figure 6. Protein gel analysis of SauUSI variants and activity assay.
(A) SDS–PAGE gel analysis of batch puriﬁed SauUSI catalytic mutants
H119A, K121A, N139A, E150A,and the wt enzyme (two isolates for
each mutant are shown). Arrow indicates the SauUSI protein
( 100kDa). (B) Activity assay of SauUSI mutants and the wt
enzyme. Lanes 1–8, T4gt DNA incubated with catalytic mutant
proteins. Protein was puriﬁed from two isolates for each mutant.
Lanes 9 and 10, T4gt digested with two concentration of batch
puriﬁed wt enzyme; lane 11, wt SauUSI (column puriﬁed). Lane 12,
uncut T4gt DNA substrate.
Table 2. Phage restriction activity of SauUSI endonuclease
Cells Dcm
+  
PFU/ml
Average
PFU/ml
Plating
efﬁciency
Exp. 1. ER2566 5.8 10
8 6.0 10
8 100%
[pBR322] 6.1 10
8
Exp. 1. ER2566 2.0 10
5 2.4 10
5 0.04%
[pBR-sauUSIR] 2.8 10
5
Exp. 1. ER2566 5.3 10
8 5.6 10
8 93.3%
[pBR-sauUSIR**] 5.9 10
8
Exp. 2. ER2566 3.2 10
8 2.9 10
8 100%
[pBR322] 2.6 10
8
Exp. 2. ER2566 9.0 10
4 9.5 10
4 0.03%
[pBR-sauUSIR] 1.0 10
5
Exp. 2. ER2566 2.9 10
8 3.1 10
8 107%
[pBR-sauUSIR**] 3.2 10
8
Cells Dcm
   
PFU/ml
Average
PFU/ml
Plating
efﬁciency
ER2566 2.7 10
9 2.8 10
9 100%
[pBR322] 2.9 10
9
ER2566 2.4 10
9 2.5 10
9 89%
[pBR-sauUSIR] 2.5 10
9
ER2566 2.9 10
9 3.0 10
9 107%
[pBR-sauUSIR**] 3.0 10
9
Plasmid pBR-sauUSIR** carries a single base deletion at nt position
85, causing a frame-shift mutation in the SauUSI endonuclease.
Figure 7. Analytical gel ﬁltration chromatography of variant
SauUSI-H119A. A Superdex 200 5/150 GL (3ml bed volume; GE
Healthcare) was run with NEBuffer 4 at 4 C at a ﬂow of 0.2ml/min.
The partition coefﬁcient (Kav) of the standard proteins ovalbumin
(43kDa), conalbumin (75kDa) and ferritin (440kDa) obtained from
two independent runs is plotted against log(mw) (ﬁlled diamonds).
The Kav of SauUSI H119A (1mg/ml) obtained from two independent
runs under the same running conditions are shown as open circles. A
relative molecular weight of 76kDa was obtained from the standard
curve (the insert equation).
Nucleic Acids Research, 2011,Vol.39, No. 13 5607constructed. Both plasmid clones were used to transform
Dcm
+E. coli host NEB10b. Table 4 shows the transform-
ation results. The transformation efﬁciency of pBR-
sauUSIR plasmid was reduced by more than four orders
of magnitude compared to the empty vector pBR322 or
pBR-sauUSIR* (insert in reverse orientation). Although
they are not isogenic strains, pBR-sauUSIR plasmid trans-
forms two E. coli B strains deﬁcient in Dcm methylase
at high efﬁciency (data not shown). This experiment has
some biological implication in the transfer SauUSI-like re-
striction genes among bacteria. The results suggest that as
long as SauUSI expression level is tightly controlled,
sauUSIR-like genes could be acquired by 5mC-methylase
carrying hosts.
Functional domain organization in SauUSI protein
BlastP analysis of SauUSI to known proteins in Genbank
showed that the protein contains at least three functional
domains (see Supplementary Figure S7) (36). The
N-terminal domain (approximately from 1 to 200aa)
contains the catalytic residues of the phospholipase D
(PLD) endonuclease family, speciﬁcally at H119-K121-
N139-E150. The HxK residues are highly conserved in
PLD family endonucleases. N/E/D are also conserved,
but can be substituted for each other in some circum-
stances. The middle part of the protein (approximately
from 201 to 625aa) carries the ATPase/helicase domain
that is highly conserved among DEXD superfamily DNA/
RNA helicases. There is a conserved putative Mg
+ +
binding site near amino acid 250, suggesting that Mg
+ +
may be required for ATP binding and hydrolysis. The
C-terminal region (approximately from 685 to 953aa)
belongs to the conserved domain family DUF3427
found in bacteria and archaea with unknown function.
We speculate that this region is the speciﬁcity domain
that recognizes 5mC or 5hmC. This domain can be
found in 255 proteins in the DUF3427 cluster (www.
kegg.org) among bacteria and archaea (see
Supplementary Table S1 for a list of SauUSI homologs
found in many pathogenic G
+ bacterial strains). Another
conserved motif prediction program found the conserved
motif of Type III REases (from 221 to 373aa in SauUSI,
Supplementary Figure S7, bottom panel), explaining why
this group of enzymes was originally annotated as putative
type III REases containing a DNA/RNA helicase domain
in Genbank. We also noted that in some sequenced bac-
terial genomes, the PLD family endonuclease exists as a
separate protein and a DNA/RNA helicase domain in an
adjacent protein, possibly regulated by a single operon
(data not shown). Site-directed mutagenesis of the
conserved residues in the helicase/ATPase and 5mC/
5hmC domains will need to be undertaken to conﬁrm
these predictions.
Interestingly, there is a conserved gene (SauUSA300_
2432) linked to the SauUSI gene (SauUSA300_2431)
that has strong amino acid sequence similarity to the
pyrophosphohydrolase and MutT/NUDIX family hydro-
lases. This protein may be involved in the breakdown of
pyrophosphate generated by ATP/dATP hydrolysis. The
SSDB gene cluster search results from the KEGG server
indicated that there are at least 60 SauUSI-like type IV
endonucleases linked to the putative pyrophospho-
hydrolases (data not shown). The function of the latter
protein remains to be examined.
Table 3. Transformation efﬁciency (number of colony forming units) using dcm
+ modiﬁed plasmid and dam
–/dcm
– DNA
Exp.1 Source of plasmid
pCN33 DH5a/
pCN38 RN4220
pCN33 BL21 dcm
–/
pCN38 RN4220
pCN33 LC1015 dam
–/
pCN38 RN4220
pCN33 LC3142 dam
–, dcm
–/
pCN38 RN4220
Recipient strains 564 1/71100 28500/99100 20/45500 10200/57900
564 type IV
– 8900/30100 8900/53900 7800/32100 7800/40700
Exp.2 Source of plasmid
pCN38 DH5a/
pCN33 RN4220
pCN38 BL21 dcm
–/
pCN33 RN4220
pCN38 LC1015 dam
–/
pCN33 RN4220
pCN38 LC3142 dam
–, dcm
–/
pCN33 RN4220
Recipient strains 564 12/17500 78800/30900 12/15890 23900/37600
564 type IV
– 34100/7320 44200/10600 64700/13300 24900/10500
Note: Here, we refer to the SauUSI isoschizomer in the S. aureus clinical strain SA564 as a type IV restriction enzyme.
Table 4. Transformation efﬁciency of pBR-sauUSIR, pBR-sauUSIR*
and pBR322 plasmids into Dcm
+ E. coli strain NEB10b
Plasmid clone Comments CFU/mg
DNA
Average
CFU/mg
pBR322 Empty vector 5.0 10
6 4.5 10
6
4.1 10
6
pBR-sauUSIR* R gene inserted in
opposite orientation
to Tc
R promoter
4.6 10
6 4.1 10
6
3.5 10
6
pBR-sauUSIR R gene insert under
Tc
R promoter
4.5 10
2 3.3 10
2
3.9 10
2
3.8 10
2
1.0 10
2
pBR-sauUSIR** SauUSI frame-shift
mutant
4.4 10
6 3.3 10
6
2.1 10
6
Plasmid pBR-sauUSIR** carries a single base deletion at nt position
85, causing a frame-shift mutation in the SauUSI endonuclease (the
mutation was introduced in PCR).
5608 Nucleic Acids Research, 2011,Vol.39, No. 13Inspection of sequenced Staphylococcus sp. genomes
revealed a few type II R-M systems that may create po-
tential substrates for SauUSI following 5mC modiﬁcation.
Staphylococcus aureus RF122 strain contains a putative
type II R–M system, whose C5 methylase has signiﬁcant
amino acid sequence similarity to GCNGC methylases
(62% aa sequence identity to M.Bsp6I, GCNGC).
Staphylococcus aureus ST398 strain carries a putative R–
M system with the predicated target sequence of CCNGG
(the putative C5 methylase displays 69% aa sequence
identity to M1.ScrFI, CCNGG). Staphylococcus aureus
TW20 and S. epidermidis RP62A strains carry a putative
orphan C5 methylase (possibly prophage encoded
multi-speciﬁcity C5 methylases) with predicted GGCC
speciﬁcity. These 5mC-modiﬁed DNA at GCNGC,
CCNGG and GGCC sites can potentially be cleaved by
SauUSI, and 5mC-modiﬁed DNA from these strains may
be restricted when transferred into S. aureus USA300
strain or Staphylococcus species with active SauUSI-like
REases. The susceptibility of these methylase-modiﬁed
DNAs to SauUSI restriction remains to be tested.
SauUSI displays low activity on short duplex oligos and
requires at least two sites for efﬁcient cleavage, possibly
SauUSI requiring extensive DNA looping and communi-
cation of two distantly bound molecules for optimal
activity, as it was observed for type I and type III
REases. In SauUSI, the C-terminal region is presumed
to contain the 5mC/5hmC recognition domain. Work is
underway to clone and express this TRD domain and to
characterize its activity. It is possible to select SauUSI
mutants that prefer to cleave 5hmC DNA. Such mutants
would be useful for epigenetic studies.
CONCLUSIONS
SauUSI is a 5mC/5hmC modiﬁcation-dependent REase.
The endonuclease activity requires ATP or dATP and
divalent cations such as Mg
+ +,M n
+ +,C a
+ + or Co
+ +.
Although the cleavage appears to be non-speciﬁc, the
initial incision (nicks or ds breaks) displays certain
sequence preferences, with S5mCNGS as the preferred
sites. Efﬁcient cleavage requires more than one site; and
the cleavage sites outside of its recognition sequence
appear to be variable (N2–N18). SauUSI is shown to
restrict Dcm
+ phage infection and Dcm
+ plasmid trans-
formation in E. coli and S. aureus clinical strain SA564.
SauUSI endonuclease expression is toxic when it is con-
stitutively expressed in a Dcm
+E. coli strain. SauUSI is a
multi-domain protein with a PLD-family endonuclease
catalytic site located at the N-terminal domain, a DNA
helicase/ATPase located in the middle part of the protein,
and a presumed 5mC/hmC TRD domain (DUF3427)
located at the C-terminus. Over 150 proteins with
25–100% amino acid sequence identity with a similar
functional domain organization are found in sequenced
bacterial genomes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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